CLINICAL_TRIALS
other
· 2025-09-15
Clinical Trial Update: JAK Signaling in Depression [Phase 2]
Summary
Phase 2 clinical trial update evaluating JAK signaling in Major Depressive Disorder, currently recruiting at Emory University.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Emory University | Conditions: Major Depressive Disorder | Phase 2 | Status: RECRUITING